Paper394873
Prednimustine in adult acute myeloid leukaemia.
Brandt L and 1 other. Cancer Chemother Pharmacol, 1979. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prednimustine in adult acute myeloid leukaemia. Papers, record 394873. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/394873
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorambucil | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Prednimustine | Major topic |
| Adult | |
| Aged | |
| Blood Cell Count | |
| Clinical Trials as Topic | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors | |
| Vincristine |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,069,571 | Acute granulocytic leukemia: treatment of the disease. | Arch Intern Med | 1976 | https://conductscience.org/library/papers/1069571 | PubMed |
| 2 | 890,652 | Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy. | Cancer | 1977 | https://conductscience.org/library/papers/890652 | PubMed |
| 3 | 793,552 | Acute myelocytic leukemia. | Arch Intern Med | 1976 | https://conductscience.org/library/papers/793552 | PubMed |
| 4 | 326,550 | Therapeutic effect of prednimustine (LEO 1031) in various types of leukaemia. | Eur J Cancer (1965) | 1977 | https://conductscience.org/library/papers/326550 | PubMed |
| 5 | 908,348 | Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil. | Eur J Cancer (1965) | 1977 | https://conductscience.org/library/papers/908348 | PubMed |
| 6 | 673,313 | Leo 1031 (NSC-134087) in gynecologic malignancies. | Oncology | 1978 | https://conductscience.org/library/papers/673313 | PubMed |
| 7 | 329,910 | A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C. | Biomedicine | 1977 | https://conductscience.org/library/papers/329910 | PubMed |
| 8 | 188,440 | Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. | Br J Haematol | 1976 | https://conductscience.org/library/papers/188440 | PubMed |
| 9 | 580,343 | Mammary tumour inhibition and subacute toxicity in rats of prednimustine and of its molecular components chlorambucil and prednisolone. | Acta Pharmacol Toxicol (Copenh) | 1978 | https://conductscience.org/library/papers/580343 | PubMed |
| 10 | 673,314 | Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031). | Oncology | 1978 | https://conductscience.org/library/papers/673314 | PubMed |
| 11 | 4,529,732 | Cell killing effectiveness of an alkylating steroid (Leo 1031). | Eur J Cancer (1965) | 1973 | https://conductscience.org/library/papers/4529732 | PubMed |
| 12 | 342,081 | Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas. | Cancer | 1978 | https://conductscience.org/library/papers/342081 | PubMed |
| 13 | 767,114 | Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma. | Eur J Cancer (1965) | 1975 | https://conductscience.org/library/papers/767114 | PubMed |
| 14 | 322,835 | Randomized clinical trial of cystosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia. | Cancer | 1977 | https://conductscience.org/library/papers/322835 | PubMed |
| 15 | 1,136,862 | Therapeutic effect of Leo 1031, an alkylating corticosteroid ester, in lymphoproliferative disorders. I. chronic lymphocytic leukaemia. | Acta Med Scand | 1975 | https://conductscience.org/library/papers/1136862 | PubMed |
| 16 | 946,596 | Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/946596 | PubMed |
| 17 | 630,199 | Prednimustine therapy for advanced prostatic cancer. | Br J Urol | 1978 | https://conductscience.org/library/papers/630199 | PubMed |
| 18 | 323,777 | [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia]. | Osterr Z Onkol | 1977 | https://conductscience.org/library/papers/323777 | PubMed |
| 19 | 1,069,570 | Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group. | Arch Intern Med | 1976 | https://conductscience.org/library/papers/1069570 | PubMed |
| 20 | 652,263 | Some metabolic aspects of a nitrogen mustard of prednisolone. | Oncology | 1978 | https://conductscience.org/library/papers/652263 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,172,410 | Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7172410 | PubMed |
| 7,139,848 | A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7139848 | PubMed |
| 6,254,684 | Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6254684 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/394873
GET https://conductscience.org/api/papers/v1/394873/references?page=2